Pharmaceutical

Compass Pathways appoints Teri Loxam as Chief Financial Officer

LONDON, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient…

4 months ago

TScan Therapeutics Appoints R. Keith Woods to its Board of Directors, Bringing Expertise in Commercialization and Global Operations

WALTHAM, Mass., Dec. 07, 2023 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the…

4 months ago

AlzeCure Presents at Redeye Investor Forum in Göteborg on December 14

STOCKHOLM, SE / ACCESSWIRE / December 07, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…

4 months ago

HFS Research recognizes CitiusTech as a Market Leader in Horizons Report: Life Sciences Service Provider 2023

PRINCETON, N.J.--(BUSINESS WIRE)--#CitiusTech--CitiusTech, a leading provider of healthcare technology services, solutions, and platforms, has been recognized as a Market Leader…

4 months ago

HFS Research recognizes CitiusTech as a Market Leader in Horizons Report: Life Sciences Service Provider 2023

PRINCETON, N.J.--(BUSINESS WIRE)--#CitiusTech--CitiusTech, a leading provider of healthcare technology services, solutions, and platforms, has been recognized as a Market Leader…

4 months ago

Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey

SOMERSET, NJ / ACCESSWIRE / December 6, 2023 / Americord, a leader in the biobanking industry, has moved its in-house…

4 months ago

Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey

SOMERSET, NJ / ACCESSWIRE / December 6, 2023 / Americord, a leader in the biobanking industry, has moved its in-house…

4 months ago

How CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No Cure

HOUSTON, TX / ACCESSWIRE / December 6, 2023 / Every form of cancer is devastating, but the unfortunate reality is…

4 months ago

How CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No Cure

HOUSTON, TX / ACCESSWIRE / December 6, 2023 / Every form of cancer is devastating, but the unfortunate reality is…

4 months ago